3篇
您的检索式：作者名="Peter McCall"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Quality of life:A critical outcome for all surgical treatmentsof gastric cancer显示文摘Surgery represents the main curative therapeutic modality for gastric cancer, and it is occasionally considered for palliation as well as prophylaxis. Most frequently, surgical outcomes are conveyed in terms of oncological outcomes such as recurrence and survival.However, quality of life(Qo L) is also important and should be considered when making treatment decisions- including the extent of and approach to surgery. Measurement of Qo L usually involves the application of questionnaires. While there are multiple Qo L questionnaires validated for use in oncology patients, there are very few that have been validated for use in those with gastric cancer. In this review, we discuss and compare the current status of Qo L questionnaires in gastric cancer. More importantly, the impact of surgery for treatment, palliation and prophylaxis of gastric cancer on Qo L will be described. These data should inform the surgeon on the optimal approach to treating gastric cancer, taking into account oncological outcomes. Knowledge gaps are also identified, providing a roadmap for future studies. | Michael D McCall Peter J Graham Oliver F Bathe | 2016 | World Journal of Gastroenterology2016，22，3： | 7 |
| 2 | Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial显示文摘 | Armando E. Giuliano Linda McCall Peter Beitsch Pat W. Whitworth Peter Blumencranz A. Marilyn Leitch Sukamal Saha Kelly K. Hunt Monica Morrow Karla Ballman | 2010 | Annals of Surgery2010，，3： | 2 |
| 3 | Haemostatic management for aortic valve replacement in a patient with advanced liver disease显示文摘Redo-sternotomy and aortic valve replacement in patients with advanced liver disease is rare and associated with a prohibitive morbidity and mortality. Refractory coagulopathy is common and a consequence of intense activation of the coagulation system that can be triggered by contact of blood with the cardiopulmonary bypass circuitry, bypass-induced fibrinolysis, plate-let activation and dysfunction, haemodilution, surgical trauma, hepatic decompensation and hypothermia. Management can be further complicated by right heart dysfunction, porto-pulmonary hypertension, poor myocardial protection, and hepato-renal syndrome. Complex interactions between coagulation/fibrinolysis and systemic inflammatory response syndrome reactions like 'post-perfusion-syndrome' also compound haemostatic failure. Given the limited information available for the specific management and prevention of cardiopulmonary bypass-induced haemostatic failure, this report serves to guide the anaesthesia and medical management of future cases of a similar kind. We discuss our multimodal management of haemostatic failure using pharmacological strategies, thromboelastography, continuous cerebral and liver oximetry, and continuous cardiac output monitoring. | Laurence Weinberg Irene Kearsey Clarissa Tjoakarfa George Matalanis Sean Galvin Scott Carson Rinaldo Bellomo Larry McNicol Peter McCall | 2014 | World Journal of Clinical Cases2014，2，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员